S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Options trading has suddenly become more reliable. (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
1970’s computer coder issues shocking A.I. warning (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Options trading has suddenly become more reliable. (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
1970’s computer coder issues shocking A.I. warning (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Options trading has suddenly become more reliable. (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
1970’s computer coder issues shocking A.I. warning (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Options trading has suddenly become more reliable. (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
He Is Giving Away Bitcoin (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
1970’s computer coder issues shocking A.I. warning (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Free Trial

Syndax Pharmaceuticals (SNDX) Insider Trading & Ownership

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)
Free SNDX Stock Alerts
$20.74
-0.54 (-2.54%)
(As of 04/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Syndax Pharmaceuticals (NASDAQ:SNDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$6.01 M
Get SNDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Syndax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SNDX Insider Buying and Selling by Quarter

Ad Paradigm Press
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
I put together this personal video [HERE]…

Syndax Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2023Briggs MorrisonDirectorSell52,855$18.27$965,660.85  
8/2/2023William MeuryDirectorSell83,000$20.46$1,698,180.00  
7/10/2023Briggs MorrisonDirectorSell52,855$20.40$1,078,242.00  
6/13/2023Keith A GoldanCFOSell577$22.31$12,872.87  
6/9/2023Briggs MorrisonDirectorSell52,855$21.18$1,119,468.90  
5/9/2023Briggs MorrisonDirectorSell52,855$21.41$1,131,625.55  
(Data available from 1/1/2013 forward)

SNDX Insider Trading Activity - Frequently Asked Questions

Who is on Syndax Pharmaceuticals's Insider Roster?

The list of insiders at Syndax Pharmaceuticals includes Alexander Nolte, Briggs Morrison, Dennis Podlesak, Fabrice Egros, Keith A Goldan, Keith Katkin, Michael A Metzger, Michael L Meyers, Peter Ordentlich, Pierre Legault, and William Meury. Learn more on insiders at SNDX.

What percentage of Syndax Pharmaceuticals stock is owned by insiders?

4.10% of Syndax Pharmaceuticals stock is owned by insiders. Learn more on SNDX's insider holdings.

Which Syndax Pharmaceuticals insiders have been selling company stock?

The following insiders have sold SNDX shares in the last 24 months: Briggs Morrison ($12,122,471.14), Dennis Podlesak ($280,574.25), Keith A Goldan ($12,872.87), Keith Katkin ($868,158.37), Michael A Metzger ($2,015,594.59), Peter Ordentlich ($1,467,078.00), Pierre Legault ($641,760.00), and William Meury ($1,698,180.00).

How much insider selling is happening at Syndax Pharmaceuticals?

Insiders have sold a total of 854,469 Syndax Pharmaceuticals shares in the last 24 months for a total of $19,106,689.22 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:SNDX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace